T1	CHEM 16 26	amlodipino
#1	AnnotatorNotes T1	C0051696; amlodipine; Organic Chemical · Pharmacologic Substance
T2	CHEM 29 38	enalapril
#2	AnnotatorNotes T2	C0014025; enalapril; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T3	DISO 52 63	hipertensos
#3	AnnotatorNotes T3	C0020538; Hypertensive disease; Disease or Syndrome
T4	DISO 68 88	enfermedad coronaria
#4	AnnotatorNotes T4	C0010068; Coronary heart disease; Disease or Syndrome
T5	DISO 122 142	enfermedad coronaria
#5	AnnotatorNotes T5	C0010068; Coronary heart disease; Disease or Syndrome
T6	DISO 144 147	EAC
#6	AnnotatorNotes T6	C0010068; Coronary heart disease; Disease or Syndrome
T7	DISO 445 448	HAS
#7	AnnotatorNotes T7	C0020538; Hypertensive disease; Disease or Syndrome
T8	PROC 260 295	Evaluar la eficacia y la tolerancia
#8	AnnotatorNotes T8	C1707887; Efficacy Study; Research Activity + C3274448; Tolerability Study; Research Activity
T9	PROC 571 575	FEVI
#9	AnnotatorNotes T9	C2114363; left ventricular ejection fraction assessment; Therapeutic or Preventive Procedure
T10	CHEM 319 329	amlodipino
#10	AnnotatorNotes T10	C0051696; amlodipine; Organic Chemical · Pharmacologic Substance
T11	CHEM 332 341	enalapril
#11	AnnotatorNotes T11	C0014025; enalapril; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T12	CHEM 358 368	amlodipino
#12	AnnotatorNotes T12	C0051696; amlodipine; Organic Chemical · Pharmacologic Substance
T13	PROC 764 776	randomizamos
#13	AnnotatorNotes T13	C0034656; Randomization; Research Activity
T14	PROC 395 408	PA diastólica
#14	AnnotatorNotes T14	C1305849; Diastolic blood pressure measurement; Diagnostic Procedure
T15	DISO 439 442	EAC
#15	AnnotatorNotes T15	C0010068; Coronary heart disease; Disease or Syndrome
T16	PROC 460 492	Estudio doble ciego, randomizado
#16	AnnotatorNotes T16	C0013072; Double-Blind Method; Research Activity + C0034656; Randomization; Research Activity
T17	DISO 542 545	EAC
#17	AnnotatorNotes T17	C0010068; Coronary heart disease; Disease or Syndrome
T18	CHEM 800 810	amlopidino
#18	AnnotatorNotes T18	C0051696; amlodipine; Organic Chemical · Pharmacologic Substance
T19	DISO 583 617	síntomas de insuficiencia cardiaca
T20	DISO 620 626	angina
#19	AnnotatorNotes T20	C0002962; Angina Pectoris; Sign or Symptom
T21	DISO 643 655	enfermedades
#20	AnnotatorNotes T21	C0012634; Disease; Disease or Syndrome
T22	CHEM 733 741	atenolol
#21	AnnotatorNotes T22	C0004147; atenolol; Organic Chemical · Pharmacologic Substance
T23	CHEM 1523 1533	amlodipino
#22	AnnotatorNotes T23	C0051696; amlodipine; Organic Chemical · Pharmacologic Substance
T24	PROC 1175 1187	PA sistólica
#23	AnnotatorNotes T24	C1306620; Systolic blood pressure measurement; Diagnostic Procedure
T25	DISO 1584 1587	HAS
#24	AnnotatorNotes T25	C0020538; Hypertensive disease; Disease or Syndrome
T26	DISO 1397 1425	edema de miembros inferiores
T27	ANAT 1406 1425	miembros inferiores
#25	AnnotatorNotes T27	C0023216; Lower Extremity; Body Part, Organ, or Organ Component | C1269079; Entire lower limb; Body Part, Organ, or Organ Component
T28	PROC 209 211	PA
#26	AnnotatorNotes T28	C0005824; Blood pressure determination; Health Care Activity
T29	CHEM 1509 1518	enalapril
#27	AnnotatorNotes T29	C0014025; enalapril; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T30	CHEM 1547 1557	amlodipino
#28	AnnotatorNotes T30	C0051696; amlodipine; Organic Chemical · Pharmacologic Substance
T31	DISO 1578 1581	EAC
#29	AnnotatorNotes T31	C0010068; Coronary heart disease; Disease or Syndrome
T32	PROC 191 207	presión arterial
#30	AnnotatorNotes T32	C0005824; Blood pressure determination; Health Care Activity
T33	CHEM 1682 1688	renina
#31	AnnotatorNotes T33	C0035094; Renin; Amino Acid, Peptide, or Protein · Enzyme
T34	CHEM 1689 1701	angiotensina
#32	AnnotatorNotes T34	C0003018; Angiotensins; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T35	ANAT 79 88	coronaria
#33	AnnotatorNotes T35	C0205042; Coronary artery; Body Part, Organ, or Organ Component | C1269008; Entire coronary artery; Body Part, Organ, or Organ Component
T36	ANAT 133 142	coronaria
#34	AnnotatorNotes T36	C0205042; Coronary artery; Body Part, Organ, or Organ Component | C1269008; Entire coronary artery; Body Part, Organ, or Organ Component
T37	ANAT 199 207	arterial
#35	AnnotatorNotes T37	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T38	PROC 410 413	PAD
#36	AnnotatorNotes T38	C1305849; Diastolic blood pressure measurement; Diagnostic Procedure
T39	PROC 520 523	PAD
#37	AnnotatorNotes T39	C1305849; Diastolic blood pressure measurement; Diagnostic Procedure
T40	ANAT 609 617	cardiaca
#38	AnnotatorNotes T40	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T41	PROC 1109 1121	randomizamos
#39	AnnotatorNotes T41	C0034656; Randomization; Research Activity
T42	PROC 665 668	PAD
#40	AnnotatorNotes T42	C1305849; Diastolic blood pressure measurement; Diagnostic Procedure
T43	PROC 963 966	PAD
#41	AnnotatorNotes T43	C1305849; Diastolic blood pressure measurement; Diagnostic Procedure
T44	PROC 1163 1166	PAD
#42	AnnotatorNotes T44	C1305849; Diastolic blood pressure measurement; Diagnostic Procedure
T45	PROC 1189 1192	PAS
#43	AnnotatorNotes T45	C1306620; Systolic blood pressure measurement; Diagnostic Procedure
T46	PROC 1268 1271	PAS
#44	AnnotatorNotes T46	C1306620; Systolic blood pressure measurement; Diagnostic Procedure
T47	PROC 1321 1324	PAD
#45	AnnotatorNotes T47	C1305849; Diastolic blood pressure measurement; Diagnostic Procedure
T48	ANAT 1674 1701	sistema renina-angiotensina
#46	AnnotatorNotes T48	C0035096; Renin-angiotensin system; Body System
T49	LIVB 42 51	pacientes
#47	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	LIVB 102 111	Pacientes
#48	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T57	Duration 702 716	cuatro semanas
T58	Frequency 826 853	de cuatro en cuatro semanas
T59	Duration 860 867	98 días
T65	PHYS 1641 1648	presión
#49	AnnotatorNotes T65	C0005823; Blood Pressure; Organism Function
T67	PHYS 395 397	PA
#50	AnnotatorNotes T67	C0005823; Blood Pressure; Organism Function
T69	PHYS 1175 1177	PA
#51	AnnotatorNotes T69	C0005823; Blood Pressure; Organism Function
T51	LIVB 113 116	pts
#52	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T52	LIVB 431 434	pts
#53	AnnotatorNotes T52	C0030705; Patients; Patient or Disabled Group
T53	LIVB 563 566	pts
#54	AnnotatorNotes T53	C0030705; Patients; Patient or Disabled Group
T54	LIVB 512 515	pts
#55	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T55	Dose 922 928	2,5/10
#56	AnnotatorNotes T55	[Dose expressed in milligrams]
T66	LIVB 1090 1093	pts
#57	AnnotatorNotes T66	C0030705; Patients; Patient or Disabled Group
T63	LIVB 1570 1573	pts
#58	AnnotatorNotes T63	C0030705; Patients; Patient or Disabled Group
T68	Dose 934 937	2,5
#59	AnnotatorNotes T68	[Dose expressed in milligrams]
T56	Date 1461 1471	el 98º día
T60	Neg_cue 547 556	Excluimos
T61	PROC 983 990	visitas
#60	AnnotatorNotes T61	C1512346; Patient Visit; Health Care Activity
A1	Assertion T53 Negated
A2	Assertion T19 Negated
A3	Assertion T20 Negated
A4	Assertion T21 Negated
A5	Assertion T22 Negated
T62	Neg_cue 1226 1229	sin
T64	CONC 1230 1241	diferencias
A6	Assertion T64 Negated
#61	AnnotatorNotes T64	C1705241; Delta (difference); Quantitative Concept
R1	Negation Arg1:T62 Arg2:T64	
R2	Combined_with Arg1:T1 Arg2:T2	
R3	Experiences Arg1:T49 Arg2:T1	
R4	Experiences Arg1:T49 Arg2:T3	
R5	Overlap Arg1:T3 Arg2:T4	
R6	Location_of Arg1:T35 Arg2:T4	
R7	Experiences Arg1:T49 Arg2:T4	
R8	Experiences Arg1:T51 Arg2:T5	
R9	Experiences Arg1:T51 Arg2:T6	
R10	Experiences Arg1:T50 Arg2:T5	
R11	Experiences Arg1:T50 Arg2:T6	
R12	Location_of Arg1:T36 Arg2:T5	
R13	Location_of Arg1:T36 Arg2:T6	
T70	Observation 149 156	estable
#62	AnnotatorNotes T70	C1282982; Patient's condition stable; Finding
R14	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T70	
R15	Has_Quantifier_or_Qualifier Arg1:T5 Arg2:T70	
R16	Experiences Arg1:T51 Arg2:T32	
R17	Location_of Arg1:T37 Arg2:T32	
R18	Location_of Arg1:T37 Arg2:T28	
R19	Experiences Arg1:T51 Arg2:T28	
R20	Experiences Arg1:T50 Arg2:T32	
R21	Experiences Arg1:T50 Arg2:T28	
R28	Combined_with Arg1:T10 Arg2:T11	
R31	Experiences Arg1:T52 Arg2:T15	
R32	Experiences Arg1:T52 Arg2:T7	
R33	Overlap Arg1:T15 Arg2:T7	
R34	Experiences Arg1:T52 Arg2:T38	
R35	Experiences Arg1:T52 Arg2:T14	
R36	Experiences Arg1:T52 Arg2:T67	
R37	Experiences Arg1:T52 Arg2:T12	
R38	Experiences Arg1:T52 Arg2:T10	
T71	Observation 375 408	normalización de la PA diastólica
#63	AnnotatorNotes T71	C0277887; Normal diastolic arterial pressure; Finding
T72	Observation 375 394;410 413	normalización de la PAD
#64	AnnotatorNotes T72	C0277887; Normal diastolic arterial pressure; Finding
R39	Experiences Arg1:T52 Arg2:T72	
R40	Experiences Arg1:T52 Arg2:T71	
R41	Causes Arg1:T10 Arg2:T72	
R42	Before Arg1:T15 Arg2:T72	
R43	Before Arg1:T15 Arg2:T71	
R44	Before Arg1:T7 Arg2:T72	
R46	Experiences Arg1:T54 Arg2:T39	
T73	Result_or_Value 524 539	>90 y <110 mmHg
R47	Has_Result_or_Value Arg1:T39 Arg2:T73	
R48	Experiences Arg1:T54 Arg2:T17	
R49	Negation Arg1:T60 Arg2:T53	
R50	Experiences Arg1:T53 Arg2:T9	
T74	Result_or_Value 576 581	< 40%
A7	Assertion T74 Negated
R51	Has_Result_or_Value Arg1:T9 Arg2:T74	
R52	Has_Result_or_Value Arg1:T53 Arg2:T74	
R53	Negation Arg1:T60 Arg2:T19	
R54	Negation Arg1:T60 Arg2:T20	
R55	Negation Arg1:T60 Arg2:T21	
T75	Quantifier_or_Qualifier 627 641	clase III y IV
R56	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T75	
R57	Location_of Arg1:T40 Arg2:T19	
T76	Quantifier_or_Qualifier 656 662	graves
#65	AnnotatorNotes T76	C1547227; Severe - Severity of Illness Code; Intellectual Product
R58	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T76	
A8	Assertion T76 Negated
T77	Result_or_Value 669 678	>110 mmHg
A9	Assertion T77 Negated
R59	Has_Result_or_Value Arg1:T42 Arg2:T77	
R60	Negation Arg1:T60 Arg2:T77	
R61	Experiences Arg1:T53 Arg2:T22	
T78	Quantifier_or_Qualifier 725 729	sólo
A10	Assertion T78 Negated
R62	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T78	
T79	CONC 755 763	wash-out
#66	AnnotatorNotes T79	C1710661; Washout Period; Temporal Concept
R63	Before Arg1:T79 Arg2:T13	
T80	CONC 690 698	wash-out
#67	AnnotatorNotes T80	C1710661; Washout Period; Temporal Concept
R64	Has_Duration_or_Interval Arg1:T80 Arg2:T57	
R65	Overlap Arg1:T9 Arg2:T80	
R66	Overlap Arg1:T19 Arg2:T80	
R67	Overlap Arg1:T20 Arg2:T80	
R68	Overlap Arg1:T21 Arg2:T80	
R69	Overlap Arg1:T42 Arg2:T80	
R70	Overlap Arg1:T80 Arg2:T22	
R71	Before Arg1:T13 Arg2:T18	
T81	PROC 817 825	seguimos
#68	AnnotatorNotes T81	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
R72	Has_Frequency Arg1:T81 Arg2:T58	
R73	Has_Duration_or_Interval Arg1:T81 Arg2:T59	
R74	Before Arg1:T13 Arg2:T81	
T82	CONC 873 878	dosis
#69	AnnotatorNotes T82	C0178602; Dosage; Quantitative Concept
R75	Has_Dose_or_Strength Arg1:T82 Arg2:T55	
R76	Has_Dose_or_Strength Arg1:T82 Arg2:T68	
T83	CONC 946 959	incrementadas
#70	AnnotatorNotes T83	C0205217; Increased; Quantitative Concept
T84	Result_or_Value 966 974	> 85mmHg
R77	Has_Result_or_Value Arg1:T43 Arg2:T84	
R79	Causes Arg1:T84 Arg2:T83	
T85	CONC 1008 1010	χ2
#71	AnnotatorNotes T85	C0008041; Chi-Square Test; Intellectual Product
T86	CONC 1012 1019	Fischer
#72	AnnotatorNotes T86	C1708064; Fisher's Exact Test; Intellectual Product
T87	CONC 1022 1042	análisis de varianza
#73	AnnotatorNotes T87	C0002780; Analysis of Variance; Quantitative Concept
T88	Observation 1147 1166	reducción de la PAD
#74	AnnotatorNotes T88	C0277885; Decreased systolic arterial pressure; Finding
R84	Location_of Arg1:T27 Arg2:T26	
R85	Overlap Arg1:T26 Arg2:T56	
T89	Observation 1147 1156;1169 1187	reducción de la PA sistólica
#75	AnnotatorNotes T89	C0277885; Decreased systolic arterial pressure; Finding
T90	Observation 1147 1162;1189 1192	reducción de la PAS
#76	AnnotatorNotes T90	C0277885; Decreased systolic arterial pressure; Finding
#77	AnnotatorNotes T26	C0239340; Edema of lower extremity; Pathologic Function
R88	Combined_with Arg1:T29 Arg2:T23	
T91	Quantifier_or_Qualifier 1558 1565	aislado
R89	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T91	
R90	Experiences Arg1:T63 Arg2:T29	
R91	Experiences Arg1:T63 Arg2:T30	
R92	Experiences Arg1:T63 Arg2:T31	
R93	Experiences Arg1:T63 Arg2:T25	
R94	Overlap Arg1:T31 Arg2:T25	
T92	Quantifier_or_Qualifier 1588 1603	estadios I y II
R95	Has_Quantifier_or_Qualifier Arg1:T31 Arg2:T92	
T93	Observation 1621 1648	normalización de la presión
#78	AnnotatorNotes T93	C0277887; Normal diastolic arterial pressure; Finding
R96	Experiences Arg1:T63 Arg2:T93	
R98	Causes Arg1:T30 Arg2:T93	
R99	Causes Arg1:T29 Arg2:T93	
R45	Before Arg1:T7 Arg2:T71	
R22	Causes Arg1:T12 Arg2:T72	
A11	Assertion T75 Negated
R23	Negation Arg1:T60 Arg2:T75	
R24	Experiences Arg1:T53 Arg2:T42	
R25	Experiences Arg1:T53 Arg2:T19	
R26	Experiences Arg1:T53 Arg2:T20	
R27	Experiences Arg1:T53 Arg2:T21	
R29	Negation Arg1:T60 Arg2:T78	
#79	AnnotatorNotes T91	C0205171; Singular; Quantitative Concept
#80	AnnotatorNotes T78	C0205171; Singular; Quantitative Concept
A12	Experiencer T49 Patient
A13	Experiencer T50 Patient
A14	Experiencer T51 Patient
A15	Experiencer T52 Patient
A16	Experiencer T54 Patient
A17	Experiencer T53 Patient
A18	Experiencer T66 Patient
A19	Experiencer T63 Patient
R30	Has_Result_or_Value Arg1:T45 Arg2:T90	
R78	Has_Result_or_Value Arg1:T24 Arg2:T89	
R80	Has_Result_or_Value Arg1:T44 Arg2:T88	
R81	Has_Result_or_Value Arg1:T14 Arg2:T71	
R83	Has_Result_or_Value Arg1:T38 Arg2:T72	
